Skip to main content
. Author manuscript; available in PMC: 2009 Sep 18.
Published in final edited form as: Pharm Res. 2007 Mar 22;24(6):1217–1224. doi: 10.1007/s11095-007-9253-0

Fig. 7.

Fig. 7

Representative in vivo NIRF images of CB activity in intracranially inoculated U87/TGL tumors. The mice used in the study had the same tumor burden as indicated by bioluminescence signal generated after intravenous injection of luciferin. NIRF Images were acquired 24 h after intravenous injection of L-PG-NIR813 (50 nmol/mouse) or D-PG-NIR813 (50 nmol/mouse) with the same NIR dye loading (10%) and the same molecular weight (17,500). NIRF signal was visualized in the mouse injected with L-PG-NIR813 but not the mouse injected with D-PG-NIR813.